Participants at the University of Ottawa Heart Institute’s 25th Annual Research Day attend a research presentation. The program included more than 75 presentations in the categories of basic science, clinical science, and allied and population health. May 7, 2012, marked the 25th Annual Research Day...
Search
Displaying 41 - 60 of 601
First Nations people are believed to experience high rates of ischemic heart disease (IHD), a leading cause of death in Canada, and an important topic of discussion among cardiovascular and allied healthcare professionals attending this year’s Canadian Cardiovascular Congress (CCC) in Toronto. Dr...
“Do these genes make me look fat?” A new study suggests the answer is yes, and for the first time ever, scientists believe it is the genes that cause inflammation that are at fault. In a study published in Nature Metabolism, a leading academic journal covering a full-spectrum of metabolic research...
The second annual Ottawa Heart Research Conference convened on May 8, bringing together an enthusiastic community of scientists and trainees to share insights on personalized cardiovascular medicine. The theme was chosen in honour of former University of Ottawa Heart Institute President and CEO...
The University of Ottawa Heart Institute (UOHI) is awaiting instruction from provincial public health authorities concerning the specific role this hospital will play in vaccinating the community under Phase Two of the government’s vaccine distribution plan. What we know: A March 5 Ontario...
In December 2010, McGraw Hill publishers released the 13th edition of Hurst’s The Heart, one of the essential texts in cardiovascular medicine for more than 40 years. This edition marks a major revision, with 19 new chapters and 59 new authors. Dr. Robert Roberts, President and CEO of the University...
In the film Minority Report, the police were able to see who was going to commit a murder before it happened, and then prevent it. Being able to do the same thing for heart attacks would be a major advance for cardiology—knowing who is going to have a heart attack and then preventing it from...
The Canadian Women's Heart Health Alliance is calling for action to address the critical gap in heart health programs designed specifically for women
Family medicine is an important setting for managing cardiovascular risk factors and preventing the onset of heart disease, as well as managing risk factors following a cardiac event. If a patient is a smoker, explained Dr. Andrew Pipe, Chief of Prevention and Rehabilitation at the University of...
Following Burgon’s talk at the International Forum, Philip Devereaux of McMaster University spoke about Canada’s unique place in the world of cardiovascular medicine. Not only is cardiovascular disease (CVD) the leading cause of death globally but by 2020, the incidence in developing countries is...
The CARDIoGRAM consortium, of which the Heart Institute is a founding member, reported finding 13 new genetic regions associated with increased risk for coronary artery disease and heart attack. CARDIoGRAM brings together research teams from around the world to pool data sets and increase their...
Dr. Ruth McPherson, an active CARDIoGRAM participant and a co-author on the interferon biomarker study, was honoured by the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) with its Special Recognition Award. Dr. McPherson, a tireless clinician and scientist, directs the...
Mutations in the gene are associated with striated muscle diseases such as cardiomyopathy and muscular dystrophy. Filling in the unknowns about a previously unexplored gene is a good way to get the attention of your peers. Heart Institute scientist Patrick Burgon is doing just that with a gene he...
The State of the Science Lecture on Women and Heart Disease by Anne Rosenfeld of the Oregon Health Sciences University made it clear that there is much to learn about the ways the disease is unique to women. What we do know indicates that risk, symptoms, progression and treatment of CVD are all...
Successfully managing heart failure is one the looming issues for cardiovascular medicine, with prevalence expected to grow significantly over the coming decades. The plenary session “Engineering Success in Heart Failure” looked at where things are headed, from therapy to devices to delivery of care...
Once again, the University of Ottawa Heart Institute had more than 40 clinical and research presentations on the program at the annual American Heart Association Scientific Sessions. These, along with other major developments in the world of cardiovascular medicine, made for a lively conference. New...
Several Heart Institute staffers offered their expertise in invited talks touching on a broad range of topics. Scientist Erik Suuronen, PhD, uses tissue engineering techniques to develop methods for regenerating damaged heart muscle. In his presentation, called “The Matrix: Stem Cell Delivery...
Some of the biggest news to come out of AHA this year was the results from preliminary clinical trials of two new LDL cholesterol-lowering drugs that show a substantial decrease in LDL levels well below the reductions seen with statins or ezetimibe alone. The new drugs belong to a class called PCSK9...
The use of stem cells for regenerating damaged heart tissue offers great potential, but many technical questions remain. Understanding which cell types are most beneficial and how they should be employed is a central issue. Several clinical trials involving stem cells were presented at AHA. Two were...
Research from around the world was presented at the 2014 American Heart Association (AHA) Scientific Sessions in November. The following highlights range from large drug trials to new information about the causes and of heart disease and the value of good heart health. Preventing Clots Following...